Measuring cell health on the SpectraMax iD3 reader with cell viability assays

Measuring cell health from the multiple vantage points of viability and apoptotic pathways can provide insight into the impacts of a variety of experimental treatments including drug candidates, pathway activators and inhibitors, and reporter genes. One of the most popular methods for assaying cell health is fluorescence detection with a microplate reader. In this application note, Molecular Devices reports the use of the EarlyTox™ Cell Viability suite of assay kits on the SpectraMax^® iD3 Multi-Mode Microplate Reader.